V. Nerme

发表

Evidence for prejunctionally located β2-adrenoceptors in the cat spleen

C. Dahlöf, A. Hedberg, V. Nerme, 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

Shallow agonist competition binding curves for beta-adrenergic receptors: the role of tight agonist binding.

A. IJzerman, H. Timmerman, G. Vauquelin, 1987, Molecular pharmacology.

Chronic isoproterenol administration causes altered beta adrenoceptor-Gs-coupling in guinea pig lung.

G. Vauquelin, V. Nerme, T. Abrahamsson, 1990, The Journal of pharmacology and experimental therapeutics.

Local proCPU (TAFI) Activation during Thrombolytic Treatment in a Dog Model of Coronary Artery Thrombosis can be Inhibited with a Direct, Small Molecule Thrombin Inhibitor (Melagatran)

V. Nerme, J. Björkman, C. Mattsson, 2002, Thrombosis and Haemostasis.

Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design

O. Fjellström, I. Nilsson, T. Olsson, 2015, PloS one.

The beta 1- and beta 2-adrenoceptor affinity of atenolol and metoprolol. A receptor-binding study performed with different radioligands in tissues from the rat, the guinea pig and man.

V. Nerme, T. Abrahamsson, B. Ek, 1988, Biochemical pharmacology.

Anti-thrombotic Effect of a PAI-1 Inhibitor in Rats Given Endotoxin

K. Pettersson, V. Nerme, M. Strömqvist, 1996, Thrombosis and Haemostasis.

Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.

V. Nerme, J. Björkman, C. Mattsson, 2005, Thrombosis research.

Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold‐dependent mechanism

V. Nerme, D. Hendriks, Y. Sim, 2004, Journal of thrombosis and haemostasis : JTH.

Endogenous noradrenaline masks beta-adrenergic receptors in rat heart membranes via tight agonist binding.

G. Vauquelin, V. Nerme, T. Abrahamsson, 1985, Biochemical pharmacology.

(+)-Sotalol causes significant occupation of β-adrenoceptors at concentrations that prolong cardiac repolarization

G. Duker, V. Nerme, O. Almgren, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Characterization of a Small Molecule Inhibitor of Plasminogen Activator Inhibitor Type 1 That Accelerates the Transition into the Latent Conformation*

S. Geschwindner, T. Sjögren, O. Fjellström, 2012, The Journal of Biological Chemistry.

PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood.

V. Nerme, J. V. van Giezen, T. Abrahamsson, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The Fab-fragment of a PAI-1 Inhibiting Antibody Reduces Thrombus Size and Restores Blood Flow in a Rat Model of Arterial Thrombosis

V. Nerme, J. V. van Giezen, T. Abrahamsson, 1997, Thrombosis and Haemostasis.

An antibody ragment against PAI-1 inhibits PAI-1 activity and stimulates fibrinolysis in vitro and in vivo

M. Hulander, P. Björquist, J. Deinum, 1994 .

Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma

P. Björquist, V. Nerme, D. Hendriks, 2003, Thrombosis and Haemostasis.

Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat

A. Hedberg, V. Nerme, H. Mattsson, 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

The β1 and β2‐adrenoceptor affinity and β1‐blocking potency of S‐ and R‐metoprolol

P. Sjöquist, V. Nerme, T. Abrahamsson, 1990 .

The JA-and f 2-adrenoceptor affinity and f-blocking potency of Sand R-metoprolol 1

V. Nerme, T. Abrahamsson, G. Wahlund, 2006 .

Spontaneous coupling of the beta-adrenergic receptor to Ns in mammalian cardiac membranes.

G. Vauquelin, V. Nerme, T. Abrahamsson, 1986, Molecular pharmacology.